MYX mayne pharma group limited

Mayne International growth

  1. 1,069 Posts.
    lightbulb Created with Sketch. 92
    targeted investment and new manufacturing revenue streams

    the Company is pursuing targeted investment and new manufacturing revenue streams. The
    Company plans to continue to drive specialty and generic product sales including driving growth in NEXTSTELLIS®
    in Australia and will continue to invest in a targeted manner in the Salisbury facility to improve our productivity
    and capabilities.
    $12m investment in partnership with the Australian Government who
    provided an $4.8m grant under their Modern Manufacturing Initiative
    (MMI) program improves capabilities and efficiencies in the Salisbury
    facility

    https://hotcopper.com.au/data/attachments/5559/5559047-96215c258e7be5b0563b71bcf3d0264d.jpg
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$5.00
Change
0.010(0.20%)
Mkt cap ! $406.2M
Open High Low Value Volume
$4.98 $5.03 $4.98 $593.4K 118.5K

Buyers (Bids)

No. Vol. Price($)
1 12024 $4.99
 

Sellers (Offers)

Price($) Vol. No.
$5.08 2631 2
View Market Depth
Last trade - 16.10pm 11/08/2025 (20 minute delay) ?
MYX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.